Phase II study of weekly gemcitabine in patients with metastatic breast cancer relapsing or failing both an anthracycline and a taxane.
- 1 March 2001
- journal article
- clinical trial
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 66 (1) , 83-87
- https://doi.org/10.1023/a:1010679127390
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Gemcitabine in Combination With Doxorubicin in Advanced Breast Cancer: Final Results of a Phase II Pharmacokinetic TrialJournal of Clinical Oncology, 2000
- Two weekly vinorelbine: administration in patients who have received at least two prior chemotherapy regimes for advanced breast cancer.European Journal Of Cancer, 2000
- Phase II study of vinorelbine administered by 96-hour infusion in patients with advanced breast carcinomaCancer, 1999
- Phase II trial of gemcitabine as prolonged infusion in metastatic breast cancerAnti-Cancer Drugs, 1999
- Prolonged infusion of gemcitabine in stage IV breast cancerAnti-Cancer Drugs, 1999
- Third line chemotherapy in patients with metastatic breast cancer: an evaluation of quality of life and cost.Breast Cancer Research and Treatment, 1999
- Phase II study of gemcitabine as first-line chemotherapy in patients with advanced or metastatic breast cancerAnti-Cancer Drugs, 1999
- 664: Phase II study of gemcltablne in patients with metastatic breast cancerEuropean Journal Of Cancer, 1997
- Activity of gemcltabine in metastatic breast cancer (MBC) patients previously treated with anthracycline-containlng regimensEuropean Journal Of Cancer, 1997
- Gemcitabine in advanced breast cancerAnti-Cancer Drugs, 1995